APA (7th ed.) Citation

Pfarr, N., Penzel, R., Endris, V., Lier, C., Flechtenmacher, C., Volckmar, A., . . . Stenzinger, A. (2017). Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance. Genes, chromosomes & cancer, 56(4), . https://doi.org/10.1002/gcc.22431

Chicago Style (17th ed.) Citation

Pfarr, Nicole, et al. "Targeted Next-generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance." Genes, Chromosomes & Cancer 56, no. 4 (2017). https://doi.org/10.1002/gcc.22431.

MLA (9th ed.) Citation

Pfarr, Nicole, et al. "Targeted Next-generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance." Genes, Chromosomes & Cancer, vol. 56, no. 4, 2017, https://doi.org/10.1002/gcc.22431.